SENORES
Invest with MTF
Invest Now
Invest in Senores Pharmaceuticals with 3.01X leverage
Performance
- Low
- ₹763
- High
- ₹790
- 52 Week Low
- ₹435
- 52 Week High
- ₹832
- Open Price₹765
- Previous Close₹771
- Volume118,307
Investment Returns
- Over 1 Month -2.03%
- Over 3 Month + 7.37%
- Over 6 Month + 42.4%
- Over 1 Year + 97.42%
Smart Investing Starts Here Start SIP with Senores Pharmaceuticals for Steady Growth!
Senores Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 40.8
- PEG Ratio
- 0.6
- Market Cap Cr
- 3,555
- P/B Ratio
- Average True Range
- 29.22
- EPS
- 18.92
- Dividend Yield
- 0
- MACD Signal
- 6.66
- RSI
- 48.09
- MFI
- 49.14
Senores Pharmaceuticals Financials
Senores Pharmaceuticals Technicals
EMA & SMA
Current Price
₹771.90
+
1.15
(0.15%)
- Bearish Moving Average 8
- Bullish Moving Average 8
- 20 Day
- ₹781.67
- 50 Day
- ₹762.83
- 100 Day
- ₹722.71
- 200 Day
- ₹649.68
Resistance and Support
774.85
- R3 813.35
- R2 801.50
- R1 786.70
- S1 760.05
- S2 748.20
- S3 733.40
Senores Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-06 | Quarterly Results | |
| 2025-07-23 | Quarterly Results & Others | To consider other business matters. |
| 2025-05-15 | Audited Results | |
| 2025-01-23 | Quarterly Results & Others | To consider other business matters. |
Senores Pharmaceuticals F&O
About Senores Pharmaceuticals
- NSE Symbol
- SENORES
- BSE Symbol
- 544319
- Managing Director
- Mr. Swapnil Jatinbhai Shah
- ISIN
- INE0RB801010
Similar Stocks to Senores Pharmaceuticals
Senores Pharmaceuticals FAQs
Senores Pharmaceuticals share price is ₹771 As on 11 December, 2025 | 07:44
The Market Cap of Senores Pharmaceuticals is ₹3554.9 Cr As on 11 December, 2025 | 07:44
The P/E ratio of Senores Pharmaceuticals is 40.8 As on 11 December, 2025 | 07:44
The PB ratio of Senores Pharmaceuticals is 4.5 As on 11 December, 2025 | 07:44
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.